IGC Pharma vs Spruce Biosciences
IGC and SPRB side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IGC and SPRB compare
Spruce Biosciences is the larger company, worth 6.5 times as much as IGC Pharma ($133M against $20.6M).
Spruce Biosciences scores higher on the StockData Score (3 against 2 for IGC Pharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IGC | SPRB |
|---|---|---|
| Size and price | ||
| Market cap | $20.6M | $133M |
| Share price | $0.199 | $46.20 |
| Change, 1 year | −48.2% | −60.0% |
| Change, 5 years | −86.1% | −79.0% |
| Beta (5Y) | 0.61 | – |
| Employees | 67 | 8 |
| StockData Score | ||
| Total score | 2 | 3 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 0 | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 18.3× | – |
| P/B | 3.2× | 2.0× (better) |
| Fair value | $0.165 | – |
| Margin of safety | −20.5% | – |
| Growth | ||
| Revenue growth (TTM) | −15.4% | – |
| Profitability | ||
| Gross margin | 21.9% | – |
| Operating margin | −987% | – |
| Net margin | −702% | – |
| Return on equity | −113% (better) | −187% |
| Return on invested capital | −136% | – |
| Financial health | ||
| Debt / equity | 0.02 (better) | 0.12 |
| Interest coverage | – | −21.3× |
| Current ratio | 0.42 | 4.83 (better) |
| Altman Z-score | −19.08 | −3.45 (better) |
| Piotroski F-score | – | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 5.1% | 69.7% |
| Held by insiders | 13.2% | 71.7% |
| Short interest, % of float | 0.44% | 65.3% |
Go deeper
- IGC stock overview
- IGC income statement
- IGC valuation and score
- SPRB stock overview
- SPRB income statement
- SPRB valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.